Family Planning Ahead
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 入组人数
- 41
- 试验地点
- 2
- 主要终点
- Perceived support in decision-making
研究概览
简要总结
Family Planning Ahead is a study that aims to improve decision-making about postpartum contraception. Family Planning Ahead will test two different strategies: a patient decision aid and a patient information leaflet.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Other
- 盲法
- None
入排标准
- 年龄范围
- 15 Years 至 —(Child, Adult, Older Adult)
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- •Currently pregnant
- •Between 28 and 38 weeks' gestation at the time of enrollment
- •Estimated due date in March, April, May, or June 2018
- •15 years or older
- •Can read and write English
- •Live in the United States
- •Share a valid email address for study purposes
- •Exclusion Criteria
- •Not currently pregnant
- •Less than 28 weeks' or more than 38 weeks' gestation at the time of enrollment
- •Estimated due date earlier than March 2018 or later than June 2018
- •Under 15 years
- •Can not read and write English
- •Do not live in the United States
- •Do not share a valid email address for study purposes
排除标准
- 未提供
研究组 & 干预措施
Patient Decision Aid
Birth Control After Pregnancy patient decision aid and supporting document
干预措施: Birth Control After Pregnancy (Other)
Patient Information Leaflet
Postpartum Birth Control patient information leaflet
干预措施: Postpartum Birth Control (Other)
结局指标
主要结局
Perceived support in decision-making
时间窗: T2 (Approximately 7-11 weeks after self-reported estimated due date)
The extent to which the person feels they received adequate support and advice without pressure to make a decision about postpartum contraceptive methods, measured using adapted versions of the Support subscale of the Decisional Conflict Scale (O'Connor, 1993).
次要结局
- Values clarity(T0 (immediately following study enrollment); T1 (one week following study enrollment))
- Perceptions of being informed(T0 (immediately following study enrollment); T1 (one week following study enrollment))
- Trust in health professional(s)(T2 (Approximately 7-11 weeks after self-reported estimated due date))
- Pressure to use a certain contraceptive method(T2 (Approximately 7-11 weeks after self-reported estimated due date))
- Likelihood of recommending the intervention to a friend(T1 (one week following study enrollment))
- Perceived utility of the intervention(T1 (one week following study enrollment))
- Concordance between preferred and actual decision-making involvement (partner): Concordant vs. discordant(T2 (Approximately 7-11 weeks after self-reported estimated due date))
- Values concordance of intended contraceptive method(s)(T0 (immediately following study enrollment); T1 (one week following study enrollment))
- Interpersonal quality of family planning care(T2 (Approximately 7-11 weeks after self-reported estimated due date))
- Shared decision-making(T2 (Approximately 7-11 weeks after self-reported estimated due date))
- Decisional uncertainty(T0 (immediately following study enrollment); T1 (one week following study enrollment))
- Intended contraceptive method(s): Most or moderately effective vs. other(T0 (immediately following study enrollment); T1 (one week following study enrollment))
- Intended contraceptive method(s): Method vs. no method or unsure(T0 (immediately following study enrollment); T1 (one week following study enrollment))
- Time pressure in decision-making(T2 (Approximately 7-11 weeks after self-reported estimated due date))
- Contraceptive method(s) prescribed in first 3 days: Most or moderately effective vs. other(T2 (Approximately 7-11 weeks after self-reported estimated due date))
- Decision self-efficacy(T0 (immediately following study enrollment); T1 (one week following study enrollment))
- Intended timing of contraceptive method(s) initiation: Not unsure vs. unsure(T0 (immediately following study enrollment); T1 (one week following study enrollment))
- Concordance between preferred and actual decision-making involvement (self): Concordant vs. discordant(T2 (Approximately 7-11 weeks after self-reported estimated due date))
- Values concordance of contraceptive method(s) used(T2 (Approximately 7-11 weeks after self-reported estimated due date))
- Contraceptive method(s) prescribed in first 60 days: LARC vs. other(T2 (Approximately 7-11 weeks after self-reported estimated due date))
- Contraceptive method(s) used: LARC vs. other(T2 (Approximately 7-11 weeks after self-reported estimated due date))
- Timing of decision about contraceptive method(s): During pregnancy vs. since giving birth(T2 (Approximately 7-11 weeks after self-reported estimated due date))
- Likelihood of reviewing the intervention in the future(T1 (one week following study enrollment))
- Effective decision(T2 (Approximately 7-11 weeks after self-reported estimated due date))
- Intended contraceptive method(s): LARC vs. other(T0 (immediately following study enrollment); T1 (one week following study enrollment))
- Concordance between preferred and actual decision-making involvement (health professional(s)): Concordant vs. discordant(T2 (Approximately 7-11 weeks after self-reported estimated due date))
- Contraceptive method(s) prescribed in first 60 days: Most or moderately effective vs. other(T2 (Approximately 7-11 weeks after self-reported estimated due date))
- Contraceptive method(s) used: Method vs. no method(T2 (Approximately 7-11 weeks after self-reported estimated due date))
- Contraceptive method(s) prescribed in first 3 days: LARC vs. other(T2 (Approximately 7-11 weeks after self-reported estimated due date))
- Contraceptive method(s) used: Most or moderately effective vs. other(T2 (Approximately 7-11 weeks after self-reported estimated due date))
研究者
Rachel L. Thompson
Assistant Professor, The Dartmouth Institute
Dartmouth-Hitchcock Medical Center
